Testing the Addition of the Anti-cancer Viral Therapy Telomelysinâ„¢ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery
NRG Oncology
NRG Oncology
Royal Marsden NHS Foundation Trust
Sanford Health
University of Oxford
Advaxis, Inc.
Pfizer
H. Lee Moffitt Cancer Center and Research Institute
Karyopharm Therapeutics Inc
The University of Texas Medical Branch, Galveston